|
|
|
|
|
|
|
|
Endometriosis: where are we and where are we going?
Abstract
Endometriosis currently affects ~5.5
million reproductive-aged women in the U.S. with symptoms such as
painful periods (dysmenorrhea),
chronic pelvic pain, pain with intercourse
(dyspareunia), and infertility. It is defined as the presence of
endometrial tissue
outside the uterine cavity and is found
predominately attached to sites within the peritoneal cavity. Diagnosis
for endometriosis
is solely made through surgery as no consistent
biomarkers for disease diagnosis exist. There is no cure for
endometriosis
and treatments only target symptoms and not the
underlying mechanism(s) of disease. The nature of individual
predisposing
factors or inherent defects in the endometrium,
immune system, and/or peritoneal cavity of women with endometriosis
remains
unclear. The literature over the last 5 years
(2010–2015) has advanced our critical knowledge related to hormones,
hormone
receptors, immune dysregulation, hormonal
treatments, and the transformation of endometriosis to ovarian cancer.
In this review,
we cover the aforementioned topics with the goal
of providing the reader an overview and related references for further
study
to highlight the progress made in endometriosis
research, while concluding with critical areas of endometriosis research
that
are urgently needed.
Future research will clarify the likely complex interaction among genetic alterations, estrogen exposure, inflammatory cytokines, and the immunologic microenvironment in the transformation of endometriosis to endometrioid and clear cell ovarian and primary peritoneal cancers. Treatment of these cancers will hopefully improve with the use of targeted and immunologic therapies that address the underlying causes of malignant transformation.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.